Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
We have studied the influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. In a double-blind, placebo-controlled trial of immunotherapy in 40 adult hay fever sufferers, clinical improvement was accompanied by a decrease in the size of the late-phase skin response. When the immunotherapy-treated group was compared with the placebo group, analysis of skin biopsies obtained 24 h after intradermal allergen revealed a significant reduction in the number of infiltrating CD3+ (P = 0.04) and CD4+ (P = 0.009) cells and a trend for a decrease in EG2+ eosinophils (P = 0.08). Treatment did not influence allergen-induced recruitment of CD8+ cells, neutrophils, or macrophages. Unexpected increases in expression of CD25 (P = 0.006) and HLA-DR (P = 0.007) were observed in the actively treated group. In situ hybridization using a panel of riboprobes demonstrated "TH2-type" (IL-4, IL-5) cytokine mRNA responses in both groups of patients. In contrast, significant hybridization for IL-2 (8/16 patients, P = 0.02) and for interferon-gamma (6/16 patients, P = 0.04) was observed only in the actively treated group. These findings indicate that immunotherapy is associated with suppression of allergen-induced CD4+ T lymphocyte infiltration, but among the cells that are recruited, there is upregulation of CD25 and HLA-DR. At least in this model, immunotherapy does not appear to affect expression of TH2-pattern cytokines in response to allergen exposure, but expression of mRNA for Th1-type cytokines was enhanced in half of the patients. The results support the view that immunotherapy may possibly be working through induction of T cell tolerance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores
Plaut, M., Pierce, J. H., Watson, C. J., Hanley-Hyde, J., Nordan, R. P., & Paul, W. E. (1989) · Nature · doi:10.1038/339064a0 · Cited by 1,170
Kay, A. B., Ying, S., Varney, V, Gaga, M., Durham, S. R., Moqbel, R., Wardlaw, A. J., & Hamid, Q. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.3.775 · Cited by 659
Self-citationWodnar-Filipowicz, A., Heusser, C. H., & Moroni, C. (1989) · Nature · doi:10.1038/339150a0 · Cited by 480
Varney, V. A., Gaga, M., Frew, A. J., Aber, V. R., Kay, A. B., & Durham, S. R. (1991) · BMJ · doi:10.1136/bmj.302.6771.265 · Cited by 384
Self-citationCONTROLLED TRIAL OF HYPOSENSITISATION TO DERMATOPHAGOIDES PTERONYSSINUS IN CHILDREN WITH ASTHMA
Warmer, J. O., Soothill, J. F., Price, J. F., & Hey, E. N. (1978) · The Lancet · doi:10.1016/s0140-6736(78)91630-6 · Cited by 342
Lichtenstein, L. M., Ishizaka, K., Norman, P. S., Sobotka, A. K., & Hill, B. M. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107204 · Cited by 342
Kita, H., Ohnishi, T., Okubo, Y., Weiler, D., Abrams, J. S., & Gleich, G. J. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.3.745 · Cited by 334
Frew, A. J., & Kay, A. B. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.12.4158 · Cited by 298
Self-citationRak, S., Löwhagen, O., & Venge, P. (1988) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(88)90021-8 · Cited by 263
Desreumaux, P., Janin, A., Colombel, J. F., Prin, L., Plumas, J., Emilie, D., Torpier, G., Capron, A., & Capron, M. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.1.293 · Cited by 239
Cited by
GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION
PAUWELS, R. A. (1996) · Arerugī/Arerugi · doi:10.15036/arerugi.45.792 · Cited by 9,994
Allergic Rhinitis and Its Impact on Asthma
Bousquet, J., van Cauwenberge, P., & Khaltaev, N. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.118891 · Cited by 3,588
Allergen immunotherapy: Therapeutic vaccines for allergic diseases A WHO position paper
Bousquet, J., Lockey, R., & Malling, H.-J. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70271-4 · Cited by 1,581
Long-Term Clinical Efficacy of Grass-Pollen Immunotherapy
Durham, S. R., Walker, S. M., Varga, E.-M., Jacobson, M. R., O'Brien, F., Noble, W., Till, S. J., Hamid, Q. A., & Nouri-Aria, K. T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908123410702 · Cited by 1,373
Self-citationKay, A. B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440106 · Cited by 1,368
Self-citationAllergen immunotherapy: A practice parameter third update
Cox, L., Nelson, H., Lockey, R., Calabria, C., Chacko, T., Finegold, I., Nelson, M., Weber, R., Bernstein, D. I., Blessing-Moore, J., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.09.034 · Cited by 1,256
The Journal of Allergy and Clinical Immunology
(1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70212-5 · Cited by 1,093
Jutel, M., Akdis, M., Budak, F., Aebischer‐Casaulta, C., Wrzyszcz, M., Blaser, K., & Akdis, C. A. (2003) · European Journal of Immunology · doi:10.1002/eji.200322919 · Cited by 915
Immunological mechanisms of allergen-specific immunotherapy
Larché, M., Akdis, C. A., & Valenta, R. (2006) · Nature Reviews Immunology · doi:10.1038/nri1934 · Cited by 849
Mechanisms of allergen-specific immunotherapy
Akdis, C. A., & Akdis, M. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.030 · Cited by 803
Akbari, O., Freeman, G. J., Meyer, E. H., Greenfield, E. A., Chang, T. T., Sharpe, A. H., Berry, G., DeKruyff, R. H., & Umetsu, D. T. (2002) · Nature Medicine · doi:10.1038/nm745 · Cited by 791
Allergen Immunotherapy: Therapeutic Vaccines for Allergic Diseases
Bousquet, J., Lockey, R., Malling, H. J., Alvarez-Cuesta, E., Canonica, G. W., Chapman, M. D., Creticos, P. J., Dayer, J. M., Durham, S. R., Demoly, P., et al. (1998) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)63136-5 · Cited by 736
Self-citationAllergen injection immunotherapy for seasonal allergic rhinitis
Calderon, M. A., Alves, B., Jacobson, M., Hurwitz, B., Sheikh, A., & Durham, S. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001936.pub2 · Cited by 678
Self-citationHansen, G., Berry, G., DeKruyff, R. H., & Umetsu, D. T. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5155 · Cited by 629
Grass Pollen Immunotherapy Induces Mucosal and Peripheral IL-10 Responses and Blocking IgG Activity
Nouri-Aria, K. T., Wachholz, P. A., Francis, J. N., Jacobson, M. R., Walker, S. M., Wilcock, L. K., Staple, S. Q., Aalberse, R. C., Till, S. J., & Durham, S. R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.3252 · Cited by 564
Self-citationInduction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy
Francis, J. N., Till, S. J., & Durham, S. R. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.1570 · Cited by 526
Self-citationRomagnani, S. (1999) · Inflammatory Bowel Diseases · doi:10.1097/00054725-199911000-00009 · Cited by 520
Müller, U., Akdis, C. A., Fricker, M., Akdis, M., Blesken, T., Bettens, F., & Blaser, K. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70402-6 · Cited by 456
The role of lymphocytes in allergic disease
Romagnani, S. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.104575 · Cited by 446
Till, S. J., Francis, J. N., Nouri-Aria, K., & Durham, S. R. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.03.024 · Cited by 434
Self-citationDurham, S. R., Ying, S., Varney, V. A., Jacobson, M. R., Sudderick, R. M., Mackay, I. S., Kay, A. B., & Hamid, Q. A. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)70205-1 · Cited by 412
Self-citationvan Neerven, R. J. J., Wikborg, T., Lund, G., Jacobsen, B., Brinch-Nielsen, A., Arnved, J., & Ipsen, H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2944 · Cited by 384
In vivo expression of IL-12 and IL-13 in atopic dermatitis
Hamid, Q., Naseer, T., Minshall, E. M., Song, Y. L., Boguniewicz, M., & Leung, D. Y. M. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)70246-4 · Cited by 382
Self-citationChinese Society of Allergy Guidelines for Diagnosis and Treatment of Allergic Rhinitis
Cheng, L., Chen, J., Fu, Q., He, S., Li, H., Liu, Z., Tan, G., Tao, Z., Wang, D., Wen, W., et al. (2018) · Allergy, Asthma & Immunology Research · doi:10.4168/aair.2018.10.4.300 · Cited by 361
Di Rienzo, V., Marcucci, F., Puccinelli, P., Parmiani, S., Frati, F., Sensi, L., Canonica, G. W., & Passalacqua, G. (2003) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2003.01587.x · Cited by 350
Oldfield, W., Larché, M., & Kay, A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09332-7 · Cited by 347
Self-citationImmunologic changes associated with allergen immunotherapy
Durham, S. R., & Till, S. J. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70079-x · Cited by 338
Self-citationYing, S., Durham, S. R., Corrigan, C. J., Hamid, Q., & Kay, A. B. (1995) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.12.5.7742012 · Cited by 335
Self-citationEBNER, C., SIEMANN, U., BOHLE, B., WILLHEIM, M., WIEDERMANN, U., SCHENK, S., KLOTZ, F., EBNER, H., KRAFT, D., & SCHEINER, O. (1997) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1997.tb01252.x · Cited by 329
Peptide-based therapeutic vaccines for allergic and autoimmune diseases
Larché, M., & Wraith, D. C. (2005) · Nature Medicine · doi:10.1038/nm1226 · Cited by 326
Kay, A. B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101113440206 · Cited by 321
Self-citationRobinson, D. S., Larché, M., & Durham, S. R. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200423595 · Cited by 313
Self-citationAkdis, C. A., Akdis, M., Blesken, T., Wymann, D., Alkan, S. S., Müller, U., & Blaser, K. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118963 · Cited by 312
Noninjection routes for immunotherapy
Canonica, G. W., & Passalacqua, G. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.129 · Cited by 283
Purello‐D'Ambrosio, F., Gangemi, S., Merendino, R. A., Isola, S., Puccinelli, P., Parmiani, S., & Ricciardi, L. (2001) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2001.01027.x · Cited by 281
Immunological mechanisms of allergen-specific immunotherapy
Jutel, M., & Akdis, C. A. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02589.x · Cited by 279
Allergic Rhinitis and its Impact on Asthma update: Allergen immunotherapy
Passalacqua, G., & Durham, S. R. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.01.045 · Cited by 277
Self-citationTh2 cells and GATA-3 in asthma: new insights into the regulation of airway inflammation
Ray, A., & Cohn, L. (1999) · Journal of Clinical Investigation · doi:10.1172/jci8204 · Cited by 273
Hansen, G., McIntire, J. J., Yeung, V. P., Berry, G., Thorbecke, G. J., Chen, L., DeKruyff, R. H., & Umetsu, D. T. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7589 · Cited by 269
Regulation of the development of type 2 T-helper cells in allergy
Romagnani, S. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90002-7 · Cited by 268
The regulation of allergy and asthma
Umetsu, D. T., & DeKruyff, R. H. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00413.x · Cited by 266
Pilette, C., Nouri-Aria, K. T., Jacobson, M. R., Wilcock, L. K., Detry, B., Walker, S. M., Francis, J. N., & Durham, S. R. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4658 · Cited by 256
Self-citationT Helper 1 Cells and Interferon γ Regulate Allergic Airway Inflammation and Mucus Production
Cohn, L., Homer, R. J., Niu, N., & Bottomly, K. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.9.1309 · Cited by 255
Regulatory T Cells Control the Development of Allergic Disease and Asthma
Umetsu, D. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(03)00004-6 · Cited by 210
Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy
Senti, G., Graf, N., Haug, S., Rüedi, N., von Moos, S., Sonderegger, T., Johansen, P., & Kündig, T. M. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.07.019 · Cited by 203
Allergy testing in children: why, who, when and how?
Høst, A., Andrae, S., Charkin, S., Diaz‐Vázquez, C., Dreborg, S., Eigenmann, P. A., Friedrichs, F., Grinsted, P., Lack, G., Meylan, G., et al. (2003) · Allergy · doi:10.1034/j.1398-9995.2003.00238.x · Cited by 196
“The main immunological long-term effect is a switch of allergen induced cytokine profile from TH2 to a TH1-like pattern (53).”
BackgroundTherapeutic manipulation of immune tolerance in allergic disease
Akdis, M., & Akdis, C. A. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2653 · Cited by 195
“Whereas earlier studies emphasized a switch from T H 2 cells to T H 1 cells in peripheral bloo”
ResultClinical efficacy of specific immunotherapy to cat dander: a double-blind placebo-controlled trial
VARNEY, V. A., EDWARDS, J., TABBAH, K., BREWSTER, H., MAVROLEON, G., & FREW, A. J. (1997) · Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy · doi:10.1046/j.1365-2222.1997.1220903.x · Cited by 164
Self-citationmRNA vaccination as a safe approach for specific protection from type I allergy
Weiss, R., Scheiblhofer, S., Roesler, E., Weinberger, E., & Thalhamer, J. (2012) · Expert Review of Vaccines · doi:10.1586/erv.11.168 · Cited by 42
Metadata
- Authors
- Varney, V. A., Hamid, Q. A., Gaga, M., Ying, S., Jacobson, M., Frew, A. J., Kay, A. B., & Durham, S. R.
- Venue
- Journal of Clinical Investigation
- Published
- 1993-08-01
- Volume
- 92
- Issue
- 2
- Pages
- 644-651
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2032260549
- Cited by
- 466
- References
- 28
- FWCI
- 7.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.